Hedley Mary Lynne
Transactions
50
Companies
9
Filings
11
CIK
0001340823
Recent Transactions
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
Companies
9Abraxis BioScience, Inc.
Executive VP of Ops & CSO
bluebird bio, Inc.
Director
- $CNTA
Centessa Pharmaceuticals plc
Director
- $LLY
ELI LILLY & Co
Director
MGI PHARMA INC
Exec VP & Chief Scientific Off
Receptos, Inc.
Director
- $TPST
Tempest Therapeutics, Inc.
Director
TESARO, Inc.
Director, Pres.&Chief Scientific Officer
- $VEEV
VEEVA SYSTEMS INC
Director
Recent Filings
11- 4
Hedley Mary Lynne
Jun 24, 2026
- 4
Hedley Mary Lynne
Jun 22, 2026
- 4
Hedley Mary Lynne
Jun 3, 2026
- 4
Hedley Mary Lynne
Mar 3, 2026
- 4
Hedley Mary Lynne
Dec 16, 2025
- 4
Hedley Mary Lynne
Dec 2, 2025
- 4
Hedley Mary Lynne
Nov 18, 2025
- 4
Hedley Mary Lynne
Oct 22, 2025
- 4
Hedley Mary Lynne
Sep 17, 2025
- 4
Hedley Mary Lynne
Sep 3, 2025
- 4
Hedley Mary Lynne
Aug 19, 2025
Address
C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE, WA14 2DT